Adipogenic effects of a combination of the endocrine-disrupting compounds bisphenol a, diethylhexylphthalate, and tributyltin

Obesity Facts

Volumn 7, Issue 1, 2014, Pages 48-56

  Biemann, Ronald ^a   Fischer, Bernd ^a   Navarrete Santos, Anne ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adipogenesis; EDC; Endocrine disrupting compounds; Mesenchymal stem cells; MSC; Peroxisome proliferator activated receptor ; PPAR

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLHEXYLPHTHALATE; ENDOCRINE DISRUPTOR; TRIACYLGLYCEROL; TRIBUTYLTIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EXPOSURE; GENE EXPRESSION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; CELL PROLIFERATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MARKER GENE;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BENZHYDRYL COMPOUNDS; CELL DIFFERENTIATION; DIETHYLHEXYL PHTHALATE; DRUG COMBINATIONS; ENDOCRINE DISRUPTORS; FOOD CONTAMINATION; GENE EXPRESSION; MESENCHYMAL STROMAL CELLS; MICE; OBESITY; PHENOLS; TRIALKYLTIN COMPOUNDS; TRIGLYCERIDES;

EID: 84893695525     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000358913     Document Type: Article

References (40)

1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology 2007; 132: 2087-2102. (Pubitemid 46693751)
2. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557-567.
3. Wang Y, Lobstein T: Worldwide trends in childhood over weight and obesity. Int J Pediatr Obes 2006; 1: 11-25.
4. de Onis M, Blossner M, Borghi E: Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010; 92: 1257-1264.
5. Casals-Casas C, Desvergne B: Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 2011; 73: 135-162.
6. Thompson RC, Moore CJ, vom Saal FS, Swan SH: Plastics, the environment and human health: current consensus and future trends. Philos Trans R Soc Lond B Biol Sci 2009; 364: 2153-2166.
7. Wilson NK, Chuang JC, Morgan MK, Lordo RA, Sheldon LS: An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare. Environ Res 2007; 103: 9-20. (Pubitemid 44894404)
8. Kannan K, Takahashi S, Fujiwara N, Mizukawa H, Tanabe S: Organotin compounds, including butyltins and octyltins, in house dust from Albany, New York, USA. Arch Environ Contam Toxicol 2010; 58: 901-907.
9. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL: Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113: 391-395. (Pubitemid 40601814)
10. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM: Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 2004; 112: 331-338. (Pubitemid 38351396)
11. Nielsen JB, Strand J: Butyltin compounds in human liver. Environ Res 2002; 88: 129-133. (Pubitemid 34280785)
12. Feige JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C, Anghel SI, Grosdidier A, Lathion C, Engelborghs Y, Michielin O, Wahli W, Desvergne B: The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 2007; 282: 19152-19166. (Pubitemid 47100190)
13. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J: Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid x receptor pathway. Mol Pharmacol 2005; 67: 766-774. (Pubitemid 40365324)
14. Rubin BS, Soto AM: Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 2009; 304: 55-62.
15. Biemann R, Navarrete Santos A, Riemann D, Knelangen J, Bluher M, Koch H, Fischer B: Endocrine disrupting chemicals affect the adipogenic differentiation of mesenchymal stem cells in distinct ontogenetic windows. Biochem Biophys Res Commun 2012; 417: 747-752.
16. Chamorro-Garcia R, Sahu M, Abbey RJ, Laude J, Pham N, Blumberg B: Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal obesogen tributyltin in mice. Environ Health Perspect 2013; 121: 359-366.
17. Heindel JJ, vom Saal FS: Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 2009; 304: 90-96.
18. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K: Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84: 319-327. (Pubitemid 40542291)
19. Schmidt JS, Schaedlich K, Fiandanese N, Pocar P, Fischer B: Di(2-ethylhexyl) phthalate (DEHP) impairs female fertility and promotes adipogenesis in C3H/N mice. Environ Health Perspect 2012; 120: 1123-1129.
20. Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD: Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 2010; 202: 391-397.
21. Nahar MS, Liao C, Kannan K, Dolinoy DC: Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J Biochem Mol Toxicol 2013; 27: 116-123.
22. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P: In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect 2003; 111: 1783-1785. (Pubitemid 37419903)
23. Koch HM, Preuss R, Angerer J: Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int J Androl 2006; 29: 155-165; discussion 181-185.
24. Bernal AJ, Jirtle RL: Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 2010; 88: 938-944.
25. Dolinoy DC, Huang D, Jirtle RL: Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007; 104: 13056-13061. (Pubitemid 351737592)
26. Rajapakse N, Silva E, Kortenkamp A: Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 2002; 110: 917-921.
27. Kortenkamp A: Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 2007; 115(suppl 1):98-105.
28. Wdziekonski B, Villageois P, Dani C: Development of adipocytes from differentiated ES cells. Methods Enzymol 2003; 365: 268-277. (Pubitemid 37531554)
29. Schaedlich K, Knelangen JM, Navarrete Santos A, Fischer B: A simple method to sort ESC-derived adipocytes. Cytometry A 2010; 77: 990-995.
30. Navarrete Santos A, Tonack S, Kirstein M, Kietz S, Fischer B: Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos. Reproduction 2004; 128: 503-516. (Pubitemid 40124281)
31. Pinney DF, Emerson CP Jr: 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect 1989; 80: 221-227. (Pubitemid 19084679)
32. Glatz JF, van der Vusse GJ: Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 1996; 35: 243-282. (Pubitemid 27092444)
33. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P, Spiegelman BM: Adipocytespecific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res 1994; 22: 5628-5634.
34. Yang VW, Christy RJ, Cook JS, Kelly TJ, Lane MD: Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation. Proc Natl Acad Sci U S A 1989; 86: 3629-3633.
35. Tontonoz P, Spiegelman BM: Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008; 77: 289-312.
36. Andersen HR, Andersson AM, Arnold SF, et al: Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect 1999; 107(suppl 1):89-108. (Pubitemid 29164204)
37. Phrakonkham P, Viengchareun S, Belloir C, Lombes M, Artur Y, Canivenc-Lavier MC: Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol 2008; 110: 95-103.
38. Linehan C, Gupta S, Samali A, O'Connor L: Bisphenol A-mediated suppression of LPL gene expression inhibits triglyceride accumulation during adipogenic differentiation of human adult stem cells. PLoS One 2012; 7:e36109.
39. Kim MH, Park JS, Seo MS, Jung JW, Lee YS, Kang KS: Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/beta-catenin signalling or lipolysis. Cell Prolif 2010; 43: 594-605.
40. Jeong S, Yoon M: 17beta-estradiol inhibition of PPARgamma-induced adipogenesis and adipocyte-specific gene expression. Acta Pharmacol Sin 2011; 32: 230-238.